SU

Sai Uttam Bahirat Patil

Active Director Director DIN 06716471
DIN 06716471 First appointment Nov 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 4 historical roles
Total affiliations 7 Since Nov 2013
Shareholding value •••• Premium profile

About Sai Uttam Bahirat Patil

Data last updated:

Sai Uttam Bahirat Patil is a Director at Dycine Pharmaceuticals Limited (since 2024), Director at Maratha Entrepreneurs Association (since 2025) and Director at Pro Capital Connect Private Limited (since 2024). The companies operate in Pharma, Education & Learing and Real Estate. The 2 current companies with reported revenue have a combined latest revenue of ₹29.72 Cr; the largest is Dycine Pharmaceuticals Limited at ₹28.83 Cr (FY 2025). Earlier, Sai Uttam Bahirat Patil was an Additional Director at Sharayu Agro Industries Limited (2022) and Additional Director at Reliance Mediaworks Limited (2024) and 2 more.

DIN 06716471
Primary Designation Director
Industry Pharma
First Appointment 19 Nov 2013
Oldest Company Age 16 yrs
Largest company Dycine Pharmaceuticals Limited · ₹28.83 Cr (FY 2025)
Combined revenue ₹29.72 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dycine Pharmaceuticals Limited U74992UP2010PLC041545
Director25 Sep 20242010₹28.83 Cr (FY 2025)Active
Maratha Entrepreneurs Association U91900PN2014NPL150388
Director16 May 20252014₹88.7 Lakh (FY 2025)Active
Pro Capital Connect Private Limited U70200PN2024PTC228065
Director10 Feb 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sharayu Agro Industries Limited U15430PN2011PLC138601
Additional Director15 Mar 20222011₹563 Cr (FY 2023)Active
Reliance Mediaworks Limited U29299MH1987PLC045446
Additional Director02 Feb 20241987₹8.24 Cr (FY 2023)Under Cirp
Director19 Nov 20132013Active
Director10 Mar 20221976₹5.8 Lakh (FY 2021)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pro Capital Connect Private Limited
Dycine Pharmaceuticals Limited
Maratha Entrepreneurs Association
Sharayu Agro Industries Limited
Premium access

Shareholding and investment profile for Sai Uttam Bahirat Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sai Uttam Bahirat Patil

Sai Uttam Bahirat Patil currently holds 3 directorships: Dycine Pharmaceuticals Limited (Director, since 25 Sep 2024, revenue ₹28.83 Cr (FY 2025)); Maratha Entrepreneurs Association (Director, since 16 May 2025, revenue ₹88.7 Lakh (FY 2025)); Pro Capital Connect Private Limited (Director, since 10 Feb 2024).

Sai Uttam Bahirat Patil was first appointed on 19 Nov 2013 as Director at Saishaa Properties India Private Limited. The most recent appointment on record is 16 May 2025 at Maratha Entrepreneurs Association.

The 2 current companies of Sai Uttam Bahirat Patil that report revenue have a combined latest revenue of ₹29.72 Cr: Dycine Pharmaceuticals Limited ₹28.83 Cr (FY 2025); Maratha Entrepreneurs Association ₹88.7 Lakh (FY 2025).

Sai Uttam Bahirat Patil held 4 earlier board appointments: Sharayu Agro Industries Limited (Additional Director, 15 Mar 2022 to 30 Sep 2022); Reliance Mediaworks Limited (Additional Director, 02 Feb 2024 to 29 Dec 2024); Saishaa Properties India Private Limited (Director, 19 Nov 2013 to 06 Jul 2024); Sahakar Caterers And Reslaurent Pvt Ltd (Director, 10 Mar 2022 to 09 Jul 2024).

The current boards of Sai Uttam Bahirat Patil's companies include Abhishek Agrawal (Dycine Pharmaceuticals Limited), Alok Kumar Singh (Dycine Pharmaceuticals Limited), Garima Malik (Dycine Pharmaceuticals Limited), Piyush Kumar Singh (Dycine Pharmaceuticals Limited), Piyush Kumar Singh (Dycine Pharmaceuticals Limited), Rupesh Kumar Gupta (Dycine Pharmaceuticals Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available